- Home
- CRIS vs TKLF Comparison
CRIS vs TKLF Comparison
Compare CRIS & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | TKLF |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 15.6M |
| IPO Year | 2000 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CRIS | TKLF |
|---|---|---|
| Price | $1.05 | $2.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 119.8K | 27.8K |
| Earning Date | 11-06-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | $11,650,000.00 | ★ $302,537,158.00 |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | ★ N/A | $2.62 |
| Revenue Growth | 13.56 | ★ 37.82 |
| 52 Week Low | $1.02 | $2.10 |
| 52 Week High | $4.50 | $4.32 |
Technical Indicators
Market Signals| Indicator | CRIS | TKLF |
|---|---|---|
| Relative Strength Index (RSI) | 35.22 | 52.33 |
| Support Level | $1.14 | $2.37 |
| Resistance Level | $1.41 | $2.75 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 7.50 | 80.25 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.